ImaRx Therapeutics' Acquisition

ImaRx Therapeutics was acquired by Coronado Venture Fund on June 21, 1999.

We are a biopharmaceutical company developing and commercializing therapies for vascular disorders. Our research and development efforts are focused on therapies for stroke and other vascular disorder…

Articles about ImaRx Therapeutics' Acquisition: